HIV clinical trials are research studies that test new treatments, prevention methods, or ways to manage HIV. Unlike what many people assume, clinical trials aren't experimental dead ends—they're structured research programs where scientists study whether a new approach works better, has fewer side effects, or helps people in new ways compared to treatments already in use.
Learn About Paying Your FGUA Bill Online →
The reason these trials exist comes down to how medical progress happens. A drug or treatment idea starts in a laboratory. If it shows promise there, researchers move to testing it with actual people, in carefully controlled conditions. This is where clinical trials come in. They're the bridge between "this might work" and "this is safe and effective enough for doctors to prescribe."
For HIV specifically, clinical trials have led to the treatments that exist today. The antiretroviral drugs that allow people with HIV to live normal lifespans? Those came through clinical trials. Newer approaches—like long-acting injections you get once a month instead of daily pills, or prevention methods for people without HIV—are currently being tested in trials right now.
There are different phases of clinical trials, each serving a different purpose. Phase 1 trials focus mainly on safety and figuring out the right dose. Phase 2 trials look at whether the treatment actually works for the condition being studied. Phase 3 trials compare the new treatment to what doctors currently use, often with larger groups of people. Phase 4 trials happen after a treatment is already approved and being used, tracking long-term effects.
What this means for you: Understanding that clinical trials are structured research—not experimental guesswork—helps you think clearly about what participation actually involves and what information researchers collect.
HIV clinical trials fall into several categories based on what they're testing. Treatment trials test new drugs or drug combinations for people already living with HIV. These might investigate whether a new medication works better than current options, whether it causes fewer side effects, or whether it can be taken less frequently. For example, some current trials are testing injectable treatments that people receive every two months, rather than taking pills daily.
Free Guide to Pay by Plate Illinois Billing →
Prevention trials test whether new approaches can stop HIV infection in people who don't have the virus. This includes trials of preventive medications (like newer versions of PrEP—pre-exposure prophylaxis), long-acting injections, or even potential vaccines. Prevention trials often work with people at higher risk of HIV exposure, such as men who have sex with men, transgender people, sex workers, or people in serodiscordant relationships (where one partner has HIV and one doesn't).
Cure or remission trials represent a newer category. These explore whether researchers can eliminate HIV from the body entirely or achieve "functional cure," where HIV becomes undetectable and the immune system controls it without medication. These trials are smaller and more specialized, typically only available at major research institutions.
Adherence and support trials test whether different approaches help people take their HIV medications consistently. This might include reminder systems, simplified dosing schedules, or programs that address barriers to taking medication regularly. Some trials combine medication testing with behavioral support or mental health counseling.
Complication trials focus on people living with HIV who also have other health conditions—like heart disease, bone density problems, or liver disease—and test whether treatments affect these conditions or interact with HIV medications in important ways.
What this means for you: The type of trial matters because it determines who the researchers are looking for, what the study involves, and what questions the trial is actually trying to answer.
Clinical trials require time commitment, and the amount varies widely. Some trials involve visiting a research site once a month for routine blood tests and check-ins. Others require weekly visits. Some newer trials use telemedicine—video visits from home—for at least some appointments. A few trials request multiple visits per week, especially early in the study or during certain phases.
Free Guide to Mold Removal Methods for Walls →
Beyond visits, trials involve specific procedures. Nearly all HIV trials include blood draws because researchers need to monitor your viral load (the amount of HIV in your blood), your CD4 count (a measure of immune system health), and various other markers. Some trials add additional testing—ultrasounds, heart monitoring, bone density scans, or tissue sampling. The trial's information sheet tells you exactly what to expect.
You'll also encounter study requirements about your medical care. Most trials require that you receive your HIV care through the trial site or that you share medical records from your regular doctor with the research team. Some trials have restrictions on other medications you can take, because researchers need to know whether effects come from the trial medication or from drug interactions. If you're in a prevention trial, there may be requirements about sexual health practices or regular testing for HIV and other infections.
Privacy and data sharing are part of participation too. Your medical information becomes part of the research record. Trials have strict rules about protecting your data, but you should understand that your health information will be reviewed by research staff, possibly shared with the drug company sponsoring the trial, and potentially included in research publications (though identifiable information is removed). Before joining any trial, you receive a consent form that explains exactly how your information will be used.
Financial aspects matter practically. Most trials don't pay participants—though some offer small compensation for time and travel costs, ranging from $20 to $200 per visit depending on the study. You should ask directly about payment. Trials typically cover the cost of the study medication and testing directly related to the trial, but may not cover other medical expenses.
What this means for you: Before considering any trial, honestly assess whether you can commit to the visit schedule and procedures. A treatment that could help you doesn't actually help if you can't follow the trial's requirements consistently.
The largest source for finding HIV clinical trials is the U.S. National Institutes of Health database at ClinicalTrials.gov. This searchable database includes trials at every phase and in every location. You can search by location (state or zip code), type of trial (treatment, prevention, or other), and HIV status. The site shows trials recruiting, trials that recently started, and trials with results posted. Each trial listing includes the location, contact information, basic details about what's being tested, and a description of who the researchers are looking for.
How to Delete Your Fitbit Account Guide →
Beyond the government database, trials are often promoted by HIV service organizations in your area. These organizations—sometimes called ASOs (AIDS Service Organizations)—work directly with research sites and often recruit participants. Searching "[your city or state] HIV clinical trial" often brings up these local organizations, which can tell you about trials happening nearby.
If you receive HIV care at a hospital, university medical center, or specialized HIV clinic, ask your doctor directly whether they conduct clinical trials or know about trials you might join. Large research institutions run multiple trials simultaneously. Your provider knows your medical history and can suggest trials that actually match your situation—not just technically possible, but practically appropriate for you.
National organizations like the AIDS Treatment Activist Coalition (ATAC), Project Inform, and amfAR maintain information about ongoing trials and sometimes post trial listings on their websites. These organizations also publish plain-language explanations of what different trials are testing, which can help you understand whether a particular study addresses questions that matter to you.
Some trials specifically recruit through LGBTQ+ health centers, community health centers serving Black or Latino communities, or other specialized clinics, because researchers know these populations are affected by HIV and want diverse participation. If you're part of one of these communities, asking at your regular healthcare provider about trial opportunities is worthwhile.
International trials also exist. If you live outside the United States, ClinicalTrials.gov includes international studies, or you can contact your national HIV organization for trial information. Keep in mind that regulations and available trials differ by country.
What this means for you: Multiple pathways exist to find trials. Starting with ClinicalTrials.gov gives you the broadest view, but connecting with local HIV organizations or your regular healthcare provider often surfaces options you might miss online.
Deciding whether to join a clinical trial involves weighing genuine benefits against real uncertainties. On the benefits side: you gain close medical monitoring from researchers trained in HIV care. If you're living with HIV and struggling to afford medications or healthcare, the trial provides care at no cost. You might get access to a new treatment before it's available to the general public—which could mean fewer side effects
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.